# Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma

> **NCT07327216** · PHASE3 · RECRUITING · sponsor: **Affiliated Hospital of Guangdong Medical University** · enrollment: 180 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma (NPC)

## Interventions

- **DRUG:** Sapylin
- **DRUG:** Dexamethasone
- **COMBINATION_PRODUCT:** CCRT with Cisplatin

## Key facts

- **NCT ID:** NCT07327216
- **Lead sponsor:** Affiliated Hospital of Guangdong Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-15
- **Primary completion:** 2026-07-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07327216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07327216, "Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07327216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*